Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
Open Access
- 9 February 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (2) , e0114965
Abstract
Extensive use of Viscum album (VA) preparations in the complementary therapy of cancer and in several other human pathologies has led to an increasing number of cellular and molecular approaches to explore the mechanisms of action of VA. We have recently demonstrated that, VA preparations exert a potent anti-inflammatory effect by selectively down-regulating the COX-2-mediated cytokine-induced secretion of prostaglandin E2 (PGE2), one of the important molecular signatures of inflammatory reactions. In this study, we observed a significant down-regulation of COX-2 protein expression in VA-treated A549 cells however COX-2 mRNA levels were unaltered. Therefore, we hypothesized that VA induces destabilisation of COX-2 mRNA, thereby depleting the available functional COX-2 mRNA for the protein synthesis and for the subsequent secretion of PGE2. To address this question, we analyzed the molecular degradation of COX-2 protein and its corresponding mRNA in A549 cell line. Using cyclohexamide pulse chase experiment, we demonstrate that, COX-2 protein degradation is not affected by the treatment with VA whereas experiments on transcriptional blockade with actinomycin D, revealed a marked reduction in the half life of COX-2 mRNA due to its rapid degradation in the cells treated with VA compared to that in IL-1β-stimulated cells. These results thus demonstrate that VA-mediated inhibition of PGE2 implicates destabilization of COX-2 mRNA.Keywords
This publication has 40 references indexed in Scilit:
- Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2PLOS ONE, 2011
- Diallyl Trisulfide Inhibits Phorbol Ester–Induced Tumor Promotion, Activation of AP-1, and Expression of COX-2 in Mouse Skin by Blocking JNK and Akt SignalingCancer Research, 2010
- Phytotherapeutics: an evaluation of the potential of 1000 plantsJournal of Clinical Pharmacy and Therapeutics, 2010
- Cyclooxygenases: structural and functional insightsJournal of Lipid Research, 2009
- Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum albumas complimentary therapy in cancerBMC Cancer, 2008
- A new prostate cancer therapeutic approach: Combination of androgen ablation with COX‐2 inhibitorInternational Journal of Cancer, 2008
- Cyclooxygenase-2 Expression during Immortalization and Breast Cancer ProgressionCancer Research, 2008
- Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational InhibitionMolecular and Cellular Biology, 2007
- Anti-inflammatory effect ofViscum albumagglutinin-I (VAA-I): induction of apoptosis in activated neutrophils and inhibition of lipopolysaccharide-induced neutrophilic inflammationin vivoClinical and Experimental Immunology, 2004
- Putative Cyclooxygenase-3 Expression in Rat Brain CellsJournal of Cerebral Blood Flow & Metabolism, 2003